Literature DB >> 9396546

Diaphragmatic eventration in infants and children: is conservative treatment justified?

C Tsugawa1, K Kimura, E Nishijima, T Muraji, M Yamaguchi.   

Abstract

PURPOSE: The purpose of this study is to examine the justification of diaphragmatic plication to treat diaphragmatic eventration. A retrospective review of 50 patients who underwent diaphragmatic plication for phrenic nerve injury (PNI) or congenital muscular deficiency (CMD) of the diaphragm was conducted.
METHODS: During the last 26 years, 50 patients, aged 4 days to 7 years, were surgically treated for diaphragmatic eventration. Twenty-five patients had iatrogenic PNI and another 25 had CMD. Respiratory distress developed in all patients who had PNI and 10 required mechanical ventilatory support for 13 to 78 days (mean, 41 days) before operation. Respiratory symptoms developed in 17 of 25 patients who had CMD, and four required ventilatory support. In those who were asymptomatic, we justified surgical repair to optimize future lung growth. All patients underwent diaphragmatic plication by a thoracic approach. Reefing mattress sutures on pledgets were used for the plication.
RESULTS: In patients who had PNI, ventilatory support could be discontinued within 0 to 6 days (mean, 3 days) after operation, with a dramatic improvement in their respiratory status. Two patients required reoperation because the plication was not tight enough. Seven patients died in this series, but none because of the diaphragmatic plication.
CONCLUSION: This study suggests that symptomatic patients who have diaphragmatic eventration should be operated on immediately with an expected dramatic resolution of their respiratory problems.

Entities:  

Mesh:

Year:  1997        PMID: 9396546     DOI: 10.1016/s0022-3468(97)90473-5

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  Diaphragmatic Eventration: Autopsy Case Report.

Authors:  Murat Serdar Gurses; Filiz Eren; Nursel Türkmen Inanir; Bulent Eren; Selcuk Çetin
Journal:  Maedica (Bucur)       Date:  2016-03

Review 2.  Collagen metabolism and recurrent hiatal hernia: cause and effect?

Authors:  Amr El Sherif; Fumiaki Yano; Sumeet Mittal; Charles J Filipi
Journal:  Hernia       Date:  2006-12       Impact factor: 4.739

3.  Thoracoscopic diaphragmatic procedures under artificial pneumothorax.

Authors:  Masahito Sato; Yoshinori Hamada; Kohei Takada; Akihide Tanano; Katsuji Tokuhara; Takehiko Hatano
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

4.  Laparoscopic diaphragmatic plication: long-term results of a novel surgical technique for postoperative phrenic nerve palsy.

Authors:  T P Hüttl; M W Wichmann; B Reichart; T K Geiger; F W Schildberg; G Meyer
Journal:  Surg Endosc       Date:  2004-03       Impact factor: 4.584

Review 5.  Pleural and pericardial effusion: a potential ultrasonographic marker for the prenatal differential diagnosis between congenital diaphragmatic eventration and congenital diaphragmatic hernia.

Authors:  C Jeanty; J K Nien; J Espinoza; J P Kusanovic; L F Gonçalves; F Qureshi; S Jacques; W Lee; R Romero
Journal:  Ultrasound Obstet Gynecol       Date:  2007-04       Impact factor: 7.299

6.  Early surgical intervention for diaphragmatic paralysis in a neonate; report of a case and literature review.

Authors:  Mousa Ahmadpour-Kacho; Yadollah Zahedpasha; Abbas Hadipoor; Zahra Akbarian-Rad
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

7.  Open Transthoracic Plication of the Diaphragm for Unilateral Diaphragmatic Eventration in Infants and Children.

Authors:  Ashraf Alshorbagy; Yasser Mubarak
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-10-05

8.  Congenital diaphragmatic eventration and hernia sac compared to CDH with true defects: a retrospective cohort study.

Authors:  Kim Heiwegen; Arno Fj van Heijst; Horst Daniels-Scharbatke; Michelle Cp van Peperstraten; Ivo de Blaauw; Sanne Mbi Botden
Journal:  Eur J Pediatr       Date:  2020-01-22       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.